Introduction {#s1}
============

Bioluminescence is the emission of visible light produced by living organisms [@pone.0084023-Shimomura1], [@pone.0084023-Wilson1]. Among insects, the luminous species have been found in three Coleoptera families: Lampyridae (firefly), Elateridae (click beetle), and Phengodidae (railroad worm) [@pone.0084023-Lloyd1]. Light emission in these insects is produced by an enzymatic reaction of a luciferase (enzyme) and a luciferin (substrate). The luminescence system is essentially the same with an identical luciferin, ATP, Mg^2+^, and a highly conserved luciferase [@pone.0084023-Inouye1]. The luciferin is referred to as "firefly luciferin" or "beetle luciferin", and the chemical structure has been identified as (*S*)-2-(6′-hydroxy-2′-benzothiazolyl)-2-thiazoline-4-carboxylic acid (**I**, ᴅ-firefly luciferin), which consists of two structural units, benzothiazole and thiazoline rings ([Figure 1A](#pone-0084023-g001){ref-type="fig"}). The chirality of the carboxyl group in natural firefly luciferin was determined to be the *S* form by the chemical synthesis of ᴅ-firefly luciferin from 2-cyano-6-hydroxybenzothiazole (**III**) and ᴅ-cysteine [@pone.0084023-White1], [@pone.0084023-White2]. ʟ-Firefly luciferin with the *R* form is not used for the luminescence reaction by firefly luciferase [@pone.0084023-Seliger1]. Thus, firefly luciferase oxidizes only ᴅ-firefly luciferin to emit light and produces oxyluciferin (**II**) and CO~2~ ([Figure 1A](#pone-0084023-g001){ref-type="fig"}).

![Strategy to study on the biosynthetic pathway of firefly luciferin in an adult lantern of a living firefly by injecting the stable isotope-labeled compounds, and the bioluminescence reaction catalyzed by firefly/beetle luciferase.\
A. Proposed biosynthetic pathway of firefly luciferin (**I**) from *p*-benzoquinone and two ʟ-cysteines in an adult lantern, and the luminescence reaction of luciferin with firefly luciferase, followed by the formation of 2-cyano-6-hydroxybenzothiazole (**III**) from oxyluciferin (**II**). B. Stable isotope-labeled ʟ-cysteines used in the experiments. Asterisk indicates the position of a ^13^C atom. C. Preparation of *p*-\[D~4~\]-benzoquinone from 1,4-\[D~6~\]-hydroquinone by the oxidation reaction using silver oxide with H~2~O~2~.](pone.0084023.g001){#pone-0084023-g001}

On the other hand, in marine luminous organisms, Cypridina luciferin and coelenterazine are widely used in the luciferase reactions [@pone.0084023-Wilson1]. Coelenterazine is also used as the light-emitting substrate for the Ca^2+^-binding photoproteins such as aequorin [@pone.0084023-Head1]. Recently, we have been studying the biosyntheses of Cypridina luciferin and coelenterazine in living specimens by feeding experiments using stable isotope-labeled compounds. The incorporation of stable isotopes into the luciferin was determined by mass spectrometry [@pone.0084023-Oba1]--[@pone.0084023-Oba2]. In the luminous ostracods *Cypridina* (presently *Vargula*) *hilgendorfii* and *Cypridina noctiluca*, we concluded that Cypridina luciferin is biosynthesized from the natural amino acids of ʟ-tryptophan, ʟ-arginine, and ʟ-isoleucine [@pone.0084023-Oba1]--[@pone.0084023-Kato2], [@pone.0084023-Toya1]. Further, we demonstrated that coelenterazine is biosynthesized from two ʟ-tyrosines and ʟ-phenylalanine in the deep-sea luminous copepod *Metridia pacifica* [@pone.0084023-Oba2]. Thus, similar to the method using the radioisotope-labeled compounds, the method of mass spectral analysis accompanied by the incorporation of stable isotope-labeled compounds is useful for investigating the biosynthetic process. With regard to studies on the biosynthesis of luciferin in firefly and click beetle, four biochemical investigations involving incorporation experiments with ^14^C-labeled compounds have been reported [@pone.0084023-Okada1]--[@pone.0084023-Colepicolo1] and studies using biomimetic synthesis have also been reported [@pone.0084023-McCapra1], [@pone.0084023-McCapra2].

The initial study on the biosynthesis of firefly luciferin was reported in 1974 [@pone.0084023-Okada1]. Based on the chemical synthesis of ᴅ-firefly luciferin from 2-cyano-6-hydroxybenzothiazole and ᴅ-cysteine [@pone.0084023-White2], \[2-^14^C\]-oxyluciferin and 2-\[cyano-^14^C\]-6-hydroxybenzothiazole were chemically synthesized and were injected into the adult lantern of the Japanese firefly *Luciola cruciata.* To determine the incorporation of ^14^C-labeled compounds into firefly luciferin, ^14^C-labeled firefly luciferin with an excess of cold ᴅ-firefly luciferin was converted to its diacetate derivative and crystallized, following which the radioactivity was determined [@pone.0084023-Okada1]. From these results, 2-cyano-6-hydroxybenzothiazole (**III**) was proposed to be a candidate for the biosynthetic precursor of firefly luciferin, and oxyluciferin (**II**) could be regenerated to luciferin through 2-cyano-6-hydroxybenzothiazole in the firefly lantern. Furthermore, when cell-free extracts from the frozen lanterns were incubated with ^14^C-oxyluciferin and cysteine in the presence of ATP, the incorporation of ^14^C-oxyluciferin into firefly luciferin was increased. However, the following controversial points exist in this report: (i) The configuration of ʟ- or ᴅ-luciferin has not been not mentioned in the report. (ii) oxyluciferin is degraded to 2-cyano-6-hydroxybenzothiazole (**III**) under non-enzymatic conditions at pH 7--9. (iii) the condensation of 2-cyano-6-hydroxybenzothiazole (**III**) with ᴅ- and ʟ-cysteine proceeds spontaneously in aqueous solutions (pH 8) at room temperature [@pone.0084023-White2], [@pone.0084023-Okada1] and forms ᴅ- and ʟ-firefly luciferin, respectively; and (iv) the presence of 2-cyano-6-hydroxybenzothiazole (**III**) or an intermediate of its derivatives has not been identified in the firefly. Thus, it is still unclear whether oxyluciferin and 2-cyano-6-hydorxybenzothiazole (**III**) are not intermediates for luciferin biosynthesis and recycling intermediates from oxyluciferin to luciferin in a living firefly [@pone.0084023-Gomi1], [@pone.0084023-Niwa1].

In the second report [@pone.0084023-Okada2], the injection experiments of *p*-\[2,3,5,6-^14^C\]-benzoquinone, 1,4-\[2,3,5,6-^14^C\]-hydroquinone, ʟ-\[U-^14^C~6~\]-tyrosine, and sodium \[2-^14^C\]-acetate into adult specimens of *L. cruciata* were performed. The results indicated that *p*-benzoquinone and 1,4-hydroquinone are candidates for the biosynthetic component of firefly luciferin [@pone.0084023-Okada2]. However, there are no descriptions about the configuration of cysteine and its incorporation into the benzothiazole ring in this report [@pone.0084023-Okada2]. In addition, the presence of *p*-benzoquinone or 1,4-hydroquinone in the firefly has not been reported.

For studies on the biosynthesis of beetle luciferin, the luminous click beetle *Pyrophorus pellucens* was used in 1976 [@pone.0084023-McCapra1]. The biosynthesis of luciferin was examined by feeding experiments using the adult specimen of *P. pellucens* with a 10% sucrose solution containing ᴅ/ʟ-\[1-^14^C\]-cystine (a dimer of ᴅ- and/or ʟ-cysteine). After the addition of an excess of ᴅ-luciferin into the extracts of photophores, the ^14^C-labeled luciferin recovered by TLC was crystallized and the radioactivity was determined. The results suggested that ᴅ/ʟ-cystine was reduced to ᴅ- and ʟ-cysteine and they were incorporated into beetle luciferin and that ᴅ- and/or ʟ-cysteine are a biosynthetic unit of luciferin. In this report, the important point was that the possibility of the decarboxylation from a cysteine was predicted during benzothiazole ring formation. However, the configuration of cysteine incorporated in beetle luciferin and the incorporation of cysteine into the benzothiazole ring with decarboxylation were not revealed. Further, in 1988, the injection experiment of \[U-^14^C~6~\]-cystine into the larvae of the luminous click beetle *Pyrearinus termitilluminans* was performed, and the ^14^C-labeled luciferin was extracted and was determined by TLC without the addition of luciferin [@pone.0084023-Colepicolo1]. As a result, cysteine from \[U-^14^C~6~\]-cystine was incorporated into luciferin, similar to the case of adult *P. pellucens* [@pone.0084023-McCapra1]. Unfortunately, the configuration of \[U-^14^C~6~\]-cystine used was not described in the report and the number of \[U-^14^C~3~\]-cysteine incorporated into luciferin was not determined.

In this study, we incorporated stable isotope-labeled ʟ-cysteine, *p*-benzoquinone, and 1,4-hydroquinone into firefly luciferin in the adult lantern of a living firefly, and identified the positions of the stable isotopes incorporated into firefly luciferin by LC/ESI-TOF-MS analysis. We revealed that ᴅ- and ʟ-firefly luciferins (beetle luciferin) are biosynthesized from *p*-benzoquinone/1,4-hydorquinone with two ʟ-cysteines, accompanied by the decarboxylation of ʟ-cysteine.

Results {#s2}
=======

Injection of Stable Isotope-labeled Compounds into an Adult Lantern of *L. lateralis* {#s2a}
-------------------------------------------------------------------------------------

For incorporation experiments into firefly luciferin in an adult lantern of the firefly, the stable isotope-labeled compounds of ʟ-Cys\[U-^13^C~3~\], ʟ-Cys\[1-^13^C\], ʟ-Cys\[3-^13^C\] and/or \[D~6~\]-hydroquinone were used ([Figure 1B and 1C](#pone-0084023-g001){ref-type="fig"}). \[D~4~\]-Benzoquinone was chemically synthesized from \[D~6~\]-hydroquinone by oxidation with H~2~O~2~ and Ag~2~O ([Figure 1C](#pone-0084023-g001){ref-type="fig"}). One microliter of each isotopic compounds dissolved in sterile H~2~O was injected into the body cavity of an adult lantern using a syringe. The injected specimens were kept in a moisture chamber for 24 h, and the survived specimen was used for mass spectral analysis. The amount of the compounds injected was 550 nmol per specimen, except for *p-*benzoquinone which was 55 nmol. Owing to the toxicity of *p-*benzoquinone, the specimens injected with 550 nmol of *p-*benzoquinone were hardly survived for 24 h.

LC/ESI-TOF-MS Analysis of Stable Isotope-labeled Firefly Luciferins in the Lantern {#s2b}
----------------------------------------------------------------------------------

We have reported that a single specimen of the adult *L. lateralis* contains approximately 0.5 nmol of firefly luciferin [@pone.0084023-Oba3] and this amount is enough for analysis by LC/ESI-TOF-MS under our experimental conditions. Chemically synthesized ᴅ- and ʟ-firefly luciferins were used as authentic samples to obtain the standard mass spectrum by LC/ESI-TOF-MS ([Figure 2](#pone-0084023-g002){ref-type="fig"} and [Table S1](#pone.0084023.s014){ref-type="supplementary-material"} and [Figure S1](#pone.0084023.s001){ref-type="supplementary-material"}--[S4](#pone.0084023.s004){ref-type="supplementary-material"}). As shown in [Fig. 2](#pone-0084023-g002){ref-type="fig"}, the parent ion of ᴅ-firefly luciferin was observed at *m/z* 281 ((***a***) in [Figure 2A](#pone-0084023-g002){ref-type="fig"}). The fragment ions were formed at *m/z* 235 ((***b***) in [Figure 2A](#pone-0084023-g002){ref-type="fig"}), *m/z* 194 and *m/z* 177 ((***c***) in [Figure 2A](#pone-0084023-g002){ref-type="fig"}) by increasing the voltage of nozzle potential up to 360 V. The isotopic fragment ions of (***b***) and (***c***) were used for determining the positions of the ^13^C-labeled atom in firefly luciferin. In our injection experiments, the incorporation efficiencies of stable isotope-labeled compounds into luciferin were estimated to be between 7% and 48% by calculating the peak intensities of the isotopic ions. The incorporation experiments were repeated 2--3 times to confirm reproducibility.

![Mass spectrum of ᴅ-firefly luciferin by ESI-TOF-MS analysis.\
A. The structure of ᴅ-firefly luciferin and the predicted mass fragment ions. The parent ion of ᴅ-luciferin at *m/z* 281 (M+H)^+^ (***a***), and its fragment ions at *m/z* 235 (***b***) and 177 (***c***). B. ESI-TOF-MS analysis of synthetic ᴅ-firefly luciferin.](pone.0084023.g002){#pone-0084023-g002}

Incorporation of l-Cys\[U-^13^C~3~\] into Firefly Luciferin in the Presence of Non-isotopic 1,4-hydroquinone or p-benzoquinone {#s2c}
------------------------------------------------------------------------------------------------------------------------------

To determine whether ʟ-cysteine is a biosynthetic component for both 6-hydroxybenzothiazole and 2-thiazoline-4-carboxylate moieties in firefly luciferin ([Figure 1A](#pone-0084023-g001){ref-type="fig"}), the incorporation experiments were performed with ʟ-Cys\[U-^13^C~3~\] in the presence and absence of 1,4-hydroquinone or *p*-benzoquinone. Because *p*-benzoquinone shows high toxicity in living organisms, the concentration of *p*-benzoquinone injected was 10-fold lower than that of 1,4-hydroquinone. The results of ESI-TOF-MS analysis are summarized in [Table 1](#pone-0084023-t001){ref-type="table"}.

10.1371/journal.pone.0084023.t001

###### Relative isotopic peak intensities (%) of the parent and its fragment mass from firefly luciferin in the lantern extracts after injecting ʟ-Cys\[U-^13^C~3~\] with 1,4-hydroquinone or *p*-benzoquinone into the adult of *L. lateralis.*

![](pone.0084023.t001){#pone-0084023-t001-1}

  Number of stable isotope atom in MH^+^    Without injection   ʟ-Cys\[U-^13^C~3~\]   ʟ-Cys\[U-^13^C~3~\] +1,4-hydroquinone   ʟ-Cys\[U-^13^C~3~\]+*p*-benzoquinone                                                                            
  ---------------------------------------- ------------------- --------------------- --------------------------------------- -------------------------------------- ---------- ------- ---------- ---------- ---------- ---------- ---------- ----------
  +0                                              100.0                100.0                          100.0                                  100.0                    100.0     100.0    100.0      100.0      100.0      100.0      100.0      100.0
  +1                                              14.9                 15.1                            9.5                                    15.9                     16.7      9.4      14.4       11.1       10.1       15.1       13.5       12.5
  +2                                               9.8                  9.6                            5.1                                    9.7                    **15.0**    4.1    **33.3**   **62.4**   **51.5**   **42.4**   **58.4**   **63.1**
  +3                                               1.6                  1.3                            --                                   **8.4**                    1.8       --     **32.0**     6.1        5.4      **20.1**     11.4       5.1
  +4                                               --                   --                             --                                     2.5                       --       --       8.9      **31.8**      --        8.8      **41.3**      --
  +5                                               --                   --                             --                                      --                       --       --     **38.0**     3.7         --      **39.3**     5.5         --
  +6                                               --                   --                             --                                      --                       --       --       7.6        3.3         --        5.9        2.8         --
  +7                                               --                   --                             --                                      --                       --       --       3.1         --         --        4.3         --         --
  +8                                               --                   --                             --                                      --                       --       --        --         --         --         --         --         --

(***a***) represents the parent mass of firefly luciferin with MH^+^281 (+0, 100%). (***b***) and (***c***) represent the fragment ion mass from firefly luciferin with MH^+^235 (+0, 100%) and MH^+^177 (+0, 100%), respectively, as shown in [Fig. 2](#pone-0084023-g002){ref-type="fig"}. The numbers in bold are the significant mass peaks containing the incorporated stable isotope atoms.

i.  Injection of ʟ-Cys\[U-^13^C~3~\]: The intensities of the isotopic parent ion (***a***) at *m/z* 284 (+3, 8.4%) and the isotopic fragment ion (***b***) at *m/z* 237 (+2, 15.0%) were mainly increased; however, no significant increase in the isotopic fragment ion (***c***) was observed. These results indicated that one cysteine molecule was incorporated into the 2-thiazoline-4-carboxylate moiety but not the 6-hydroxybenzothiazole moiety in firefly luciferin ([Table 1](#pone-0084023-t001){ref-type="table"} & [Figure S5](#pone.0084023.s005){ref-type="supplementary-material"}). This result also indicated that firefly luciferin was generated from an unidentified compound having a benzothiazole and ʟ-cysteine in the lantern.

ii. Injection of ʟ-Cys\[U-^13^C~3~\] and 1,4-hydroquinone: The addition of non-isotopic 1,4-hydroquinone stimulated the incorporation efficiency of ʟ-Cys\[U-^13^C~3~\] into firefly luciferin ([Figure 3A](#pone-0084023-g003){ref-type="fig"}). The isotopic parent ions (***a*** **)** at *m/z* 283 (+2, 33.3%), 284 (+3, 32.0%) and 286 (+5, 38.0%) indicated that two ʟ-cysteine molecules were incorporated into firefly luciferin. The fragment ions (***b***) at *m/z* 237 (+2, 62.4%) and 239 (+4, 31.8%) and (***c***) at *m/z* 179 (+2, 51.5%) indicated that one carbon atom was eliminated from one of the two ʟ-cysteine molecules during the incorporation into firefly luciferin ([Figure 4](#pone-0084023-g004){ref-type="fig"}). Thus, ʟ-cysteine was independently incorporated into 6-hydroxybenzothiazole and 2-thiazoline-4-carboxylate moieties.

iii. Injection of ʟ-Cys\[U-^13^C~3~\] and *p*-benzoquinone: The incorporation pattern and efficiency of ʟ-Cys\[U-^13^C~3~\] and *p*-benzoquinone into firefly luciferin were similar to those of ʟ-Cys\[U-^13^C~3~\] and 1,4-hydroquinone, indicating that *p*-benzoquinone is also a biosynthetic component in firefly luciferin ([Figure S6](#pone.0084023.s006){ref-type="supplementary-material"}). It is known that 1,4-hydroquinone is enzymatically oxidized to produce *p*-benzoquinone in living cells. The increase in the incorporation efficiency of ʟ-Cys\[U-^13^C~3~\] into firefly luciferin by the addition of 1,4-hydroquinone or *p-*benzoquinone showed that they are other biosynthetic components of firefly luciferin.

![Incorporation of 1,4-hydroquinone and ^13^C-labeled ʟ-cysteines into firefly luciferin in an adult lantern of *L. lateralis*.\
A. Predicted firefly luciferins incorporated from 1,4-hydroquinone and ʟ-Cys\[U-^13^C~3~\]. B. Predicted firefly luciferins incorporated from 1,4-hydroquinone and ʟ-Cys\[1-^13^C~3~\]. C. Predicted firefly luciferins incorporated from 1,4-hydroquinone and ʟ-Cys\[3-^13^C~3~\]. The number in parenthesis on the right indicates the number of ^13^C-atom incorporated into firefly luciferin. Asterisk indicates the position of a ^13^C-atom.](pone.0084023.g003){#pone-0084023-g003}

![Mass spectra of firefly luciferin labeled with ʟ-Cys\[U-^13^C~3~\] and 1,4-hydroquinone in the adult lantern of *L. lateralis*.\
(***a***), the parent ion; (***b***) and (***c***), the fragments ions of firefly luciferin.](pone.0084023.g004){#pone-0084023-g004}

Incorporation of \[D~6~\]-hydroquinone or \[D~4~\]-benzoquinone into Firefly Luciferin in the Presence of Non-isotopic l-cysteine (l-Cys) {#s2d}
-----------------------------------------------------------------------------------------------------------------------------------------

To confirm 1,4-hydroquinone and *p*-benzoquinone as biosynthetic components for firefly luciferin, the injection experiments of \[D~6~\]-hydroquinone and \[D~4~\]-benzoquinone with ʟ-cysteine were performed as follows ([Table 2](#pone-0084023-t002){ref-type="table"}).

10.1371/journal.pone.0084023.t002

###### Relative isotopic peak intensities (%) of the parent and its fragment mass from firefly luciferin in the lantern extracts after injecting \[D~6~\]-hydroquinone or \[D~4~\]-benzoquinone into the adult of *L. lateralis.*

![](pone.0084023.t002){#pone-0084023-t002-2}

  Number of stable isotope atom in MH^+^    \[D~6~\]-hydroquinone   \[D~6~\]-hydroquinone   \[D~6~\]-hydroquinone   \[D~4~\]-benzoquinone   \[D~4~\]-benzoquinone                                                                                                     
  ---------------------------------------- ----------------------- ----------------------- ----------------------- ----------------------- ----------------------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
  +0                                                100.0                   100.0                   100.0                   100.0                   100.0            100.0      100.0      100.0      100.0      100.0      100.0      100.0      100.0      100.0      100.0
  +1                                                16.6                    15.0                     9.1                    16.4                    14.1              9.3        15.2       15.7       10.5       13.8       13.6       10.5       14.3       15.5       10.7
  +2                                                 9.8                     9.4                     6.3                    12.3                    13.8              7.8        8.8      **20.0**     6.3        11.3       11.5       4.7        10.3       11.8       6.9
  +3                                               **8.8**                 **8.4**                 **7.3**                **55.8**                **66.0**          **56.8**   **15.5**     5.0      **7.4**    **22.0**   **24.2**   **27.1**   **38.9**   **29.7**   **36.7**
  +4                                                 --                      --                      --                      7.8                     8.5              4.7        3.3        3.9        1.1        3.6        3.1        2.6        5.9        4.6        5.8
  +5                                                 --                      --                      --                      4.9                     6.0              4.8      **11.7**   **13.4**   **24.5**     2.6        2.9         --        3.3        4.1         --
  +6                                                 --                      --                      --                      --                      --                --        4.6        4.3        2.1         --         --         --         --         --         --
  +7                                                 --                      --                      --                      --                      --                --        3.0      **17.2**      --         --         --         --         --         --         --
  +8                                                 --                      --                      --                      --                      --                --      **14.4**      --         --         --         --         --         --         --         --
  +9                                                 --                      --                      --                      --                      --                --        1.5         --         --         --         --         --         --         --         --
  +10                                                --                      --                      --                      --                      --                --         --         --         --         --         --         --         --         --         --

(***a***) represents the parent mass of firefly luciferin with MH^+^281 (+0, 100%). (***b***) and (***c***) represent the fragment ions mass from firefly luciferin with MH^+^235 (+0, 100%) and MH^+^177 (+0, 100%), respectively, as shown in [Fig. 2](#pone-0084023-g002){ref-type="fig"}. The numbers in bold are the significant mass peaks containing the incorporated stable isotope atoms.

i.  Injection of \[D~6~\]-hydroquinone: The isotopic parent ion (***a***) at *m/z* 284 (+3, 8.8%) and the fragment ions (***b*** and ***c***) at *m/z* 238 (+3, 8.4%) and 180 (+3, 7.3%), respectively, indicated that \[D~6~\]-hydroquinone was incorporated into firefly luciferin ([Figure 5B](#pone-0084023-g005){ref-type="fig"}). The luciferin was biosynthesized from \[D~6~\]-hydroquinone and endogenous cysteine in the adult lantern ([Figure S7](#pone.0084023.s007){ref-type="supplementary-material"}).

ii. Injection of \[D~6~\]-hydroquinone and ʟ-Cys: The addition of non-isotopic ʟ-cysteine stimulated the incorporation of \[D~6~\]-hydroquinone into firefly luciferin ([Figure 5B](#pone-0084023-g005){ref-type="fig"}), similar to the case of the addition of 1,4-hydroquinone with ʟ-Cys\[U-^13^C~3~\] ([Figure 3A](#pone-0084023-g003){ref-type="fig"} and [Figure S8](#pone.0084023.s008){ref-type="supplementary-material"}).

iii. Injection of \[D~4~\]-benzoquinone: The isotopic parent ion (***a***) at *m/z* 284 (+3, 22.0%) and the fragment ions (***b*** and ***c***) at *m/z* 238 (+3, 24.2%) and 180 (+3, 27.1%), respectively, indicated that \[D~4~\]-benzoquinone was incorporated into firefly luciferin ([Figure 5A](#pone-0084023-g005){ref-type="fig"}), similar to from the case of \[D~6~\]-hydroquinone ([Figure S9](#pone.0084023.s009){ref-type="supplementary-material"}). Thus, *p*-benzoquinone is also a biosynthetic component for firefly luciferin.

iv. Injection of \[D~4~\]-benzoquinone and ʟ-Cys: The isotopic ion patterns of ***a***, ***b*** and ***c*** from labeled firefly luciferin were similar to those in the injection experiments using \[D~6~\]-hydroquinone, \[D~6~\]-hydroquinone with ʟ-Cys, and \[D~4~\]-benzoquinone ([Figure S10](#pone.0084023.s010){ref-type="supplementary-material"}).

![Incorporation of *p*-\[D~4~\]-benzoquinone or 1,4-\[D~6~\]-hydroquinone with ʟ-cysteines into firefly luciferin in an adult lantern of *L. lateralis*.\
A. Predicted firefly luciferins incorporated from *p*-\[D~4~\]-benzoquinone and ʟ-cysteine. B. Predicted firefly luciferins incorporated from 1,4-\[D~6~\]-hydroquinone and ʟ-cysteine. C. Predicted firefly luciferins incorporated from 1,4-\[D~6~\]-hydroquinone and ʟ-Cys\[3-^13^C~3~\]. The number in parenthesis on the right indicates the number of the stable isotope atoms incorporated into firefly luciferin. Asterisk indicates the position of a ^13^C-atom.](pone.0084023.g005){#pone-0084023-g005}

Notably, the incorporation efficiency of \[D~4~\]-benzoquinone into firefly luciferin ([Figure S9](#pone.0084023.s009){ref-type="supplementary-material"}) was higher than that of \[D~6~\]-hydroquinone ([Table 2](#pone-0084023-t002){ref-type="table"}, [Figure S7](#pone.0084023.s007){ref-type="supplementary-material"}), despite the fact that the amount of *p*-benzoquinone injected was 10 times lower than that of 1,4-hydroquinone. This result indicated that *p*-benzoquinone might be preferred over 1,4-hydroquinone for firefly luciferin synthesis, and that 1,4-hydroquinone may converted to *p*-benzoquinone and immediately used for the biosynthesis of firefly luciferin in the lantern.

Incorporation of l-Cys\[1-^13^C\] or l-Cys\[3-^13^C\] into Firefly Luciferin {#s2e}
----------------------------------------------------------------------------

It has been proposed that one carbon atom is eliminated from cysteine during the biosynthesis of firefly luciferin [@pone.0084023-McCapra1]. To identify the carbon atom eliminated from ʟ-cysteine through 6-hydroxybenzothiazole formation, the incorporation studies with ʟ-Cys\[1-^13^C\] and ʟ-Cys\[3-^13^C\] were performed in the presence of 1,4-hydroquinone ([Figure 3B, C](#pone-0084023-g003){ref-type="fig"} and [Table 3](#pone-0084023-t003){ref-type="table"}). When ʟ-Cys\[1-^13^C\] and 1,4-hydroquinone were injected, the isotopic parent ion (***a***) at *m/z* 282 (+1, 68.6%) was increased; however, the fragment ions (***b*** and ***c***) at *m/z* 236 (+1, 16.3%) and 178 (+1, 10.9%), respectively, were not increased ([Table 3](#pone-0084023-t003){ref-type="table"} and [Figure 6](#pone-0084023-g006){ref-type="fig"}).

![Mass spectra of firefly luciferin labeled with ʟ-Cys\[1-^13^C\] and 1,4-hydroquinone in the adult lantern of *L. lateralis*.\
(***a***), the parent ion; (***b***) and (***c***), the fragments ions of firefly luciferin.](pone.0084023.g006){#pone-0084023-g006}

10.1371/journal.pone.0084023.t003

###### Relative isotopic peak intensities (%) of the parent and its fragment mass from firefly luciferin in the lantern extracts after injecting ʟ-Cys\[1-^13^C\] or ʟ-Cys\[3-^13^C\] with 1,4-hydroquinone into the adult of *L. lateralis.*

![](pone.0084023.t003){#pone-0084023-t003-3}

  Number of stable isotope atom in MH^+^    ʟ-Cys\[1-^13^C\] +1,4-hydroquinone   ʟ-Cys\[3-^13^C\] +1,4-hydroquinone                                
  ---------------------------------------- ------------------------------------ ------------------------------------ ------- ---------- ---------- ----------
  +0                                                      100.0                                100.0                  100.0    100.0      100.0      100.0
  +1                                                     **68.6**                               16.3                  10.9    **63.2**   **60.6**   **42.2**
  +2                                                       16.4                                 8.4                    4.0    **42.7**   **43.3**     8.7
  +3                                                       5.8                                  1.3                    --       8.4        10.0        --
  +4                                                        --                                   --                    --       2.1        4.9         --
  +5                                                        --                                   --                    --        --         --         --

(***a***) represents the parent mass of firefly luciferin with MH^+^281 (+0, 100%). (***b***) and (***c***) represent the fragment ion mass from firefly luciferin with MH^+^235 (+0, 100%) and MH^+^177 (+0, 100%), respectively, as shown in [Fig. 2](#pone-0084023-g002){ref-type="fig"}. The numbers in bold are the significant mass peaks containing the incorporated stable isotope atoms.

In contrast, the injection of ʟ-Cys\[3-^13^C\] resulted in mass increases of the isotopic parent ions at *m/z* 282 (+1, 63.2%) and 283 (+2, 42.7%) and the fragment ions at *m/z* 236 (+1, 60.6%), 237 (+2, 43.3%) and 178 (+1, 42.2%) ([Table 3](#pone-0084023-t003){ref-type="table"} and [Figure 7](#pone-0084023-g007){ref-type="fig"}). These results indicated that the carboxyl group of ʟ-cysteine was eliminated during the formation of the benzothiazole ring in firefly.

![Mass spectra of firefly luciferin labeled with ʟ-Cys\[3-^13^C\] and 1,4-hydroquinone in the adult lantern of *L. lateralis*.\
(***a***), the parent ion; (***b***) and (***c***), the fragments ions of firefly luciferin.](pone.0084023.g007){#pone-0084023-g007}

Incorporation of \[D~6~\]-hydroquinone and l-Cys\[U-^13^C~3~\] into Firefly Luciferin {#s2f}
-------------------------------------------------------------------------------------

A double-labeling experiment using \[D~6~\]-hydroquinone and ʟ-Cys\[U-^13^C~3~\] was performed to confirm the *de novo* synthesis of firefly luciferin in the firefly lantern ([Figure 5C](#pone-0084023-g005){ref-type="fig"} and [Table 2](#pone-0084023-t002){ref-type="table"} ). The peak intensities of the isotopic parent ions (***a***) at *m/z* 284 (+3, 15.5%), 286 (+5, 11.7%) and 289 (+8, 14.4%), the fragment ions (***b***) at *m/z* 237 (+2, 20.0%), 240 (+5, 13.4%) and 242 (+7, 17.2%), and the fragment ions (***c***) at *m/z* 180 (+3, 7.4%) and 182 (+5, 24.5%) were increased, indicating that one hydroquinone and two ʟ-cysteine molecules were incorporated into firefly luciferin ([Figure 8](#pone-0084023-g008){ref-type="fig"} and [Figure S11](#pone.0084023.s011){ref-type="supplementary-material"}). Thus, two ʟ-cysteine molecules and 1,4-hydroquinone are required for the *de novo* synthesis of firefly luciferin.

![Mass spectrum of firefly luciferin labeled with ʟ-Cys\[U-^13^C\] and 1,4-\[D~6~\]-hydroquinone into the adult lantern of *L. lateralis*.](pone.0084023.g008){#pone-0084023-g008}

Identification of Endogenous d- and l-firefly Luciferin in an Adult Lantern in *L. lateralis* and Incorporation of l-Cys\[U-^13^C~3~\] into d- and l-firefly Luciferin {#s2g}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------

To characterize the chirality of firefly luciferin, firefly luciferin was extracted from the adult lantern of *L. lateralis* without racemization between ᴅ- and ʟ-luciferin (see experimental section), following which then ᴅ- and ʟ-luciferins were separated by HPLC with a chiral column ([Figure 9A](#pone-0084023-g009){ref-type="fig"}). The peak ratio of ᴅ-luciferin to ʟ-luciferin was approximately 9∶1 ([Figure 9A--c](#pone-0084023-g009){ref-type="fig"}), indicating that ʟ-luciferin was present in an adult lantern. Following this, an incorporation study of ʟ-Cys\[U-^13^C~3~\] and 1,4-hydroquinone was performed and the peak ratio of ᴅ-luciferin to ʟ-luciferin was changed to 7∶3 with an increase in ʟ-luciferin ([Figure 9A](#pone-0084023-g009){ref-type="fig"}--d). These peak fractions were collected and subsequently subjected to LC/ESI-TOF-MS analysis ([Figure 9B](#pone-0084023-g009){ref-type="fig"}). Interestingly, ʟ-cysteine was incorporated into not only ʟ-luciferin but also ᴅ-luciferin, indicating that ʟ-cysteine is a biosynthetic component of ᴅ-luciferin.

![Identification of ʟ- and ᴅ-luciferin in an adult lantern of *L. lateralis* by HPLC analysis and the incorporation of ʟ-cysteine into ᴅ- and ʟ-luciferin.\
A. Isolation of ʟ- and ᴅ-firefly luciferin by HPLC analysis with a chiral column. (a) authentic ᴅ-luciferin, (b) authentic ʟ-luciferin, (c) the extracts of *L. lateralis* lantern without injections, (d) the extracts of *L. lateralis* lantern after injection with ʟ-Cys\[U-^13^C~3~\] and 1,4-hydroquinone. The peak fractions of 1 and 2, corresponding to ʟ-luciferin and ᴅ-luciferin, respectively, are subjected to ESI-TOF-MS analysis, as shown in Fig. 9B. B. ESI-TOF-MS analyses of the HPLC fractions for ʟ-luciferin and ᴅ-luciferin, separated by HPLC analysis as in Fig.9A--d. (a) ʟ-luciferin separated from the lantern. (b) ᴅ-luciferin separated from the lantern.](pone.0084023.g009){#pone-0084023-g009}

Identification of Free 1,4-hydroquinone and Arbutin in Firefly Lantern {#s2h}
----------------------------------------------------------------------

As described above, 1,4-hydroquinone is a biosynthetic component of firefly luciferin. To examine the presence of free 1,4-hydroquinone or its storage forms such as arbutin in the lantern of an adult firefly, we analyzed the lantern extracts by HPLC. Under our analytical conditions, free 1,4-hydroquinone was not detected in the lantern extracts. However, we successfully detected arbutin in the extracts by HPLC analysis ([Figure 10A](#pone-0084023-g010){ref-type="fig"}). After the arbutin fraction was hydrolyzed with HCl ([Figure 10C](#pone-0084023-g010){ref-type="fig"}), the hydrolyzed sample was subjected to HPLC analysis and the fluorescence peak of 1,4-hydroquinone was detected ([Figure 10B](#pone-0084023-g010){ref-type="fig"}). Furthermore, the structure of 1,4-hydroquinone in the hydrolyzed sample was confirmed as an acetylated derivative by LC/ESI-TOF-MS ([Figure S12](#pone.0084023.s012){ref-type="supplementary-material"}). The content of 1,4-hydroquinone after hydrolysis was estimated to be 144±34 pmol per specimen using the standard curve of 1,4-hydroquinone (data not shown). This result suggested that 1,4-hydroquinone would be released from a glycoside derivative such as arbutin in the lantern and used for the biosynthesis of firefly luciferin.

![Identification of arbutin in *L. lateralis* by HPLC analysis.\
A. HPLC analysis of the extracts from an adult *L. lateralis* by using a fluorescence detector. (a) authentic arbutin, (b) the extracts of *L. lateralis* lantern. The arbutin fraction between the vertical dashed lines is used for hydrolysis as in Fig. 10C. B. HPLC analysis of the hydrolyzed arbutin fraction in Fig. 10A--b. (a) authentic 1,4-hydroquinone (labeled peak 1) containing benzoquinone (labeled peak 2), (b) the hydrolyzed products of the peak fraction between the dashed lines in Fig. 10A--b. Asterisk indicates 1,4-hydroquinone from arbutin. C. A scheme of acid hydrolysis of arbutin to 1,4-hydroquinone by acid treatment with HCl.](pone.0084023.g010){#pone-0084023-g010}

Discussion {#s3}
==========

Studies on the biosynthesis of luciferin in firefly and click beetle were initiated in the early 1970's using ^14^C-labeled compounds. A hypothesis that firefly luciferin (beetle luciferin) is biosynthesized from *p*-benzoquinone and two cysteines was proposed [@pone.0084023-Okada1]--[@pone.0084023-McCapra1], [@pone.0084023-McCapra2]. In this report, we have identified the biosynthetic components of firefly luciferin by mass spectroscopy with stable isotope-labeled compounds. The ^13^C-labeled ʟ-cysteine, *p*-\[D~4~\]-benzoquinone and 1,4-\[D~6~\]-hydroquinone were incorporated into firefly luciferin in an adult lantern of a firefly. The incorporation experiment with ʟ-Cys\[U-^13^C~3~\] indicated that ʟ-cysteine was incorporated into both the benzothiazole and thiazoline unit of firefly luciferin ([Figures 1](#pone-0084023-g001){ref-type="fig"} and [3](#pone-0084023-g003){ref-type="fig"}). This is the first demonstration that two ʟ-cysteine molecules are the biosynthetic components of firefly luciferin ([Figure 3](#pone-0084023-g003){ref-type="fig"} and [Table 2](#pone-0084023-t002){ref-type="table"}). Furthermore, the incorporation of ʟ-\[1-^13^C\]-cysteine and ʟ-\[3-^13^C\]-cysteine into firefly luciferin revealed that the carboxyl group of ʟ-\[1-^13^C\]-cysteine was eliminated during the benzothiazole ring formation of firefly luciferin ([Figure 3](#pone-0084023-g003){ref-type="fig"} and [Table 1](#pone-0084023-t001){ref-type="table"}), followed by the thiazoline ring formation of firefly luciferin ([Figure 11](#pone-0084023-g011){ref-type="fig"}). This result clearly explains the previous observation that the radioisotope activity of ^14^C-labeled firefly luciferin was lost following acetylation at the carboxyl group of luciferin [@pone.0084023-McCapra1]. Previously, a biosynthetic pathway of firefly luciferin from *p*-benzoquinone and a dipeptide of cysteine was proposed [@pone.0084023-McCapra2]. This possibility was not acceptable from the evidence that the carboxyl group from ʟ-cysteine was eliminated. However, it is unclear whether the carbon atoms at the C2' in the benzothiazole unit and the C2 in the thiazoline unit were derived from the carbon atom at the C2 or C3 position of ʟ-cysteine in our experiments ([Figure 7](#pone-0084023-g007){ref-type="fig"}).

![Proposed biosynthetic pathway of firefly luciferin in the lantern of adult firefly.](pone.0084023.g011){#pone-0084023-g011}

On the other hand, the results of incorporation studies with *p*-\[D~4~\]-benzoquinone and 1,4-\[D~6~\]-hydroquinone were in good agreement with those of a study with^14^C-lableled *p*-benzoquinone and 1,4-hydroquinone [@pone.0084023-Okada2]. Thus, *p*-benzoquinone and 1,4-hydroquinone are components of the benzothiazole unit of firefly luciferin.

It is known that quinones including *p*-benzoquinone and its derivatives are found in some beetles (Coleoptera) [@pone.0084023-Gnanasunderam1]--[@pone.0084023-Holliday1] and *p*-benzoquinone is a metabolite produced by the oxidation of 1,4-hydroquinone [@pone.0084023-Reinhard1]. Because *p*-benzoquinone shows high toxicity to living organisms, the concentration of *p*-benzoquinone was 10-fold lower than that of 1,4-hydroquinone in our injection experiments. The incorporation efficiency of *p*-benzoquinone into firefly luciferin was higher than that of 1,4-hydroquinone, suggesting that *p*-benzoquinone may be a preferred substance for the biosynthesis of firefly luciferin in the adult lantern. We detect arbutin, but not 1,4-hydroquionone in the firefly. It is considered that 1,4-hydroquione with low toxicity is stored as a non-toxic form of glycoside such as arbutin and released by the digestive enzyme β-glucosidase [@pone.0084023-Reinhard1] and possibly oxidized to *p*-benzoquinone immediately for luciferin synthesis. However, the possibility that 1,4-hydroquinone is a direct biosynthetic precursor still remains.

Recently, the conversion of ʟ-luciferin to ᴅ-luciferin in firefly has been proposed by the racemization through ʟ-luciferyl CoA to ᴅ-luciferyl CoA, followed by its hydrolysis with an esterase [@pone.0084023-Niwa1]. ʟ-Luciferyl CoA was produced from ʟ-luciferin by "firefly luciferase" in the presence of ATP, Mg^2+^ and CoA, although ʟ-luciferin is a potent inhibitor of firefly luciferase [@pone.0084023-Lembert1], [@pone.0084023-daSilva1]. However, another possibility that the ᴅ-configuration in luciferin is formed during the thiazoline ring formation accompanied by the conversion of ʟ-form to ᴅ-form of cysteine still remains.

In this report, we determined the absolute configuration of the isotope-labeled firefly luciferin by HPLC analysis with a chiral column ([Figure 9](#pone-0084023-g009){ref-type="fig"}) and found that ʟ-cysteine was incorporated into not only ʟ-luciferin but also ᴅ-luciferin, indicating that ʟ-cysteine is a biosynthetic component of ᴅ-luciferin. The mechanism by which ᴅ-firefly luciferin is biosynthesized from ʟ-cysteine remains unclear.

In conclusion, we have demonstrated that the 6-hydroxybenzothiazole moiety in ᴅ- and ʟ-firefly luciferins is biosynthesized from 1,4-hydroquinone/benzoquinone with ʟ-cysteine, accompanied by the elimination of the carboxyl group of ʟ-cysteine, and that the 2-thiazoline-4-carboxylate moiety is derived from the second ʟ-cysteine in the adult lantern of the firefly.

Materials and Methods {#s4}
=====================

Chemicals {#s4a}
---------

The stable isotope-labeled chemicals, ʟ-\[U-^13^C~3~\]-cysteine (ʟ-Cys\[U-^13^C~3~\]: 98% isotopic purity), ʟ-\[1-^13^C\]-cysteine (ʟ-Cys\[1-^13^C\]: 99% isotopic purity), ʟ-\[3-^13^C\]-cysteine (ʟ-Cys\[3-^13^C\]: 99% isotopic purity) and 1,4-\[D~6~\]-hydroquinone (\[D~6~\]-hydroquinone: 98% isotopic purity), were purchased from Cambridge Isotope Laboratories (Andover, MA), and the chemical purities of these compounds were over 98%. *p*-\[2,3,5,6-D\]-Benzoquinone (\[D~4~\]-benzoquinone) was prepared from \[D~6~\]-hydroquinone as previously reported [@pone.0084023-Derikvand1]. In brief, the reaction mixture of \[D~6~\]-hydroquinone (348 mg, 3.05 mmol) and Ag~2~O (60.1 mg, 0.259 mmol) in methanol (6 mL) was stirred for 5 min, and a solution of 30% aq. H~2~O~2~ (0.75 mL, 7.5 mmol) in methanol (10 mL) was added dropwise and continuously stirred for 40 min at room temperature. The reaction mixture was diluted to 30 mL with H~2~O and extracted twice with 30 mL of diethyl ether and evaporated. The yellow needle-like crystals (310 mg, 90.4% yield) of \[D~4~\]-benzoquinone were obtained and were further purified by a silica gel column (Wakogel C-300, Wako Pure Chemicals, Osaka, Japan), eluted by *n*-hexane: ethyl acetate = 4∶1. The chemical purity of \[D~4~\]-benzoquinone on HPLC analysis was over 98%, and its isotopic purity was over 98% by ESI-TOF-MS analysis (negative mode) (data not shown). The non-isotopic chemicals were obtained from commercial sources: ᴅ-firefly luciferin potassium salt and arbutin (Wako Pure Chemicals); ʟ-cysteine, ᴅ-cysteine and *p*-benzoquinone (Kanto Chemical, Tokyo, Japan); 1,4-hydroquinone (Nacalai Tesque, Kyoto, Japan). ʟ-Firefly luciferin was kindly provided by Dr. Yoshiaki Toya (Aichi Univ. of Education, Aichi, Japan).

Specimens of Firefly, *Luciola Lateralis* {#s4b}
-----------------------------------------

The adult specimens of Japanese firefly *Luciola lateralis* (Lampyridae, Coleoptera) reared in aquarium [@pone.0084023-Oba4] were kindly provided by Mr. Haruyoshi Ikeya (Toin Gakuen High School, Yokohama, Japan).

Injection of Stable Isotope-labeled Compounds into the Adult Lantern of *L. lateralis* {#s4c}
--------------------------------------------------------------------------------------

The stock solutions of stable isotope-labeled and non-labeled compounds were prepared by dissolving compound in sterile H~2~O to be 550 mM, excepting for 55 mM of *p*-benzoquinone and \[D~4~\]-benzoquinone. For incorporation experiments, 1 µL of the stock solution was injected into the adult lantern of a female *L. lateralis* (within 4 days after adult emergence) using a microsyringe (701RN 10 µL SYR; Hamilton, Reno, NV) ([Figure S13](#pone.0084023.s013){ref-type="supplementary-material"}). After keeping fireflies in a moisture chamber at 24±2°C for 24 h, the living specimens injected were frozen in liquid nitrogen and stored at −80°C.

Extraction of the Labeled Firefly Luciferin from an Adult Lantern of *L. lateralis* {#s4d}
-----------------------------------------------------------------------------------

A single lantern was separated from a frozen specimen using a razor blade, and was homogenized in a tube with 70 µL of hot H~2~O using a plastic pestle in a heating block at 95°C for 5 min to inactivate luciferase activity. The homogenate was centrifuged at 17,400×g for 3 min at 4°C, and the resultant supernatant was filtrated by an Ultrafree-MC centrifugal filter (0.45 µm; Millipore, Billerica, MA). The filtrate obtained was washed twice by *n*-hexane (60 µL) and 5 µL of aqueous layer (ca. 30 µL) was subjected to LC/ESI-TOF-MS analysis. Under above extraction conditions at 95°C, the racemization of ᴅ/ʟ-firefly luciferin could be partially occurred.

Identification of d- and l-luciferin in an Adult Lantern of *L. lateralis* by HPLC Analysis with a Chiral Column {#s4e}
----------------------------------------------------------------------------------------------------------------

To avoid racemization of ᴅ/ʟ-firefly luciferin during the extraction from an adult lantern, a single lantern was homogenized in 70 µL of methanol at 4°C instead of hot H~2~O at 95°C. Under above conditions, the racemization of ᴅ-luciferin to ʟ-luciferin was not occurred at 4°C for 60 min. In contrast, by incubating ᴅ-luciferin in methanol at 70°C for 60 min, 21% of ʟ-firefly luciferin was yielded by racemization (data not shown). Methanol extracts (18 µL) were analyzed by reversed-phase HPLC equipped with a chiral column, CHIRALCEL OD-RH (4.6×150 mm; Daicel Chemical Industry, Tokyo, Japan) and a fluorescence detector (FP-1520, Jasco). HPLC conditions: mobile phase, 27% acetonitrile in H~2~O containing 0.1% formic acid; flow rate, 1.0 mL/min; excitation, 330 nm; emission, 530 nm. The eluted fractions containing ᴅ- or ʟ-luciferin (1.2 mL) were collected, concentrated to ∼20 µL using a rotary evaporator (N-N series, EYELA, Tokyo, Japan), and applied to LC/ESI-TOF-MS analysis.

LC/ESI-TOF-MS Analysis {#s4f}
----------------------

LC/ESI-TOF-MS analysis was performed by electrospray ionization-ion trap-mass spectrometry (ESI-TOF-MS) on an Agilent 1100 HPLC system (Agilent Technologies, Santa Clara, CA) with a Mariner Biospectrometry Workstation (Applied Biosystems, Foster City, CA). HPLC conditions: column, Unison UK-C8 (75×2 mm; Imtakt, Kyoto, Japan); mobile phase, a linear gradient of methanol in H~2~O containing 0.1% formic acid from 50% to 90% for 12 min; flow rate 0.1 mL/min; sprit ratio, 1∶20 (5 µL/min); nozzle potential, 120--360 V; ion mode, positive. Under these conditions, the retention time of the mass ion peaks for ᴅ- and ʟ-luciferin with its fragments was at approximately 5.5 min. The mass value was calibrated using angiotensin I (*m/z* = 324.9272 and 432.9603) and neurotensin (*m/z* = 558.3111) as external standards.

Isolation and Identification of Arbutin from *L. lateralis* {#s4g}
-----------------------------------------------------------

To isolate arbutin from *L. lateralis*, two frozen female adults were homogenized in 400 µL of methanol on ice. After centrifugation at 17,400×g for 3 min, the supernatant was filtrated by a 0.45 µm centrifugal filter. The filtrate was dried down under N~2~ and suspended in 100 µL of 80% methanol. After incubating for 60 min on ice, the precipitate was removed by centrifugation at 17,400×g for 30 min. The resultant supernatant was dried down and dissolved in 50 µL of H~2~O. The aqueous solution was washed three times with 50 µL of ethyl acetate, filtrated, and subjected to reversed-phase HPLC equipped with a Develosil ODS-UG-5 (4.6×250 mm; Nomura Chemical, Aichi, Japan) and a fluorescence detector (FP-1520, Jasco). HPLC conditions: mobile phase, 5% methanol in H~2~O; flow rate, 1.0 mL/min; excitation, 280 nm; emission, 320 nm.

To identify arbutin, the peak fraction (1.2 mL) containing arbutin was concentrated to 10 µL, and 5 µL was used for acid hydrolysis to release 1,4-hydroquinone from arbutin. The total reaction mixture (200 µL) containing 1.1 N HCl was incubated at 95°C for 1 h. After adding 200 µL of H~2~O, the mixture was extracted three times with 400 µL of diethyl ether and the extracts were dried down under N~2~. The resultant solid was immediately dissolved in 30 µL of H~2~O and was analyzed by reversed-phase HPLC equipped with a Develosil ODS-UG-5 (4.6×250 mm) and a fluorescence detector. HPLC conditions: mobile phase, 25% methanol in H~2~O; flow rate, 0.8 mL/min; excitation, 290 nm; emission, 338 nm.

To identify 1,4-hydroquinone in firefly, the hydrolyzed extracts obtained from 10 specimens were acetylated in 200 µL of acetic anhydride (Wako Pure Chemicals) and 1 µL of sulfuric acid (Wako Pure Chemicals) at room temperature for 5 min [@pone.0084023-Zhao1]. The acetylated products were subjected to LC/ESI-TOF-MS analysis as described above.

Supporting Information {#s5}
======================

###### 

**Calculated mass spectra of firefly luciferin based on the natural isotopic abundance.** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Mass spectra of synthetic ᴅ-firefly luciferin.** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Mass spectra of synthetic ʟ-firefly luciferin.** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Mass spectra of firefly luciferin extracted from an adult lantern of** ***L. lateralis*** **without injecting the labeled compounds.** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Injecting of ʟ-Cys\[U-^13^C~3~\] into an adult lantern of** ***L. lateralis.*** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Injecting of ʟ-Cys\[U-^13^C~3~\] and** ***p*** **-benzoquinone into an adult lantern of** ***L. lateralis.*** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Injecting of 1,4-\[D~6~\]-hydroquinone into an adult lantern of** ***L. lateralis.*** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Injecting of 1,4-\[D~6~\]-hydroquinone and ʟ-Cys into an adult lantern of** ***L. lateralis.*** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Injecting of** ***p*** **-\[D~4~\]-benzoquinone into an adult lantern of** ***L. lateralis.*** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Injecting of** ***p*** **-\[D~4~\]-benzoquinone and ʟ-Cys into an adult lantern of** ***L. lateralis.*** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Injecting of 1,4-\[D~6~\]-hydroquinone and ʟ-Cys\[U-^13^C~3~\] into an adult lantern of** ***L. lateralis.*** (*a*), the parent ion of firefly luciferin; (*b*) and (*c*), the fragment ions of firefly luciferin.

(TIF)

###### 

Click here for additional data file.

###### 

**Mass spectrum of acetylated 1,4-hydroquinone isolated from arbutin in** ***L. lateralis*** **.**

(TIF)

###### 

Click here for additional data file.

###### 

**Photograph of the procedure to inject the chemicals into the adult lantern of** ***L. lateralis*** **(female) using a syringe.**

(TIF)

###### 

Click here for additional data file.

###### 

**Relative isotopic peak intensities (%) of calculated firefly luciferin, synthetic ᴅ-firefly luciferin and ʟ-firefly luciferin.**

(DOC)

###### 

Click here for additional data file.
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